“The premise of Lantern is to use the most current advances in machine learning, artificial intelligence, and genomics to help rescue and develop cancer drugs faster and cheaper and with lower risk so we can get them to patients in a more personalized manner,” says Panna Sharma, CEO of Lantern Pharma.Sharma was drawn t